CADRX
Price
$22.75
Change
-$0.17 (-0.74%)
Updated
Nov 14 closing price
RGAHX
Price
$80.30
Change
-$0.73 (-0.90%)
Updated
Nov 14 closing price
Ad is loading...

CADRX vs RGAHX

Header iconCADRX vs RGAHX Comparison
Open Charts CADRX vs RGAHXBanner chart's image
Columbia Large Cap Growth Opp Inst2
Price$22.75
Change-$0.17 (-0.74%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R5E
Price$80.30
Change-$0.73 (-0.90%)
VolumeN/A
CapitalizationN/A
CADRX vs RGAHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CADRX vs. RGAHX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CADRX is a Buy and RGAHX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 306B vs. CADRX (1.35B). RGAHX pays higher dividends than CADRX: RGAHX (0.64) vs CADRX (0.00). CADRX was incepted earlier than RGAHX: CADRX (11 years) vs RGAHX (9 years). CADRX is a more actively managed with annual turnover of: 74.00 vs. RGAHX (31.00). CADRX has a lower initial minimum investment than RGAHX: CADRX (0) vs RGAHX (250). CADRX annual gain was more profitable for investors over the last year : 33.20 vs. RGAHX (30.15). RGAHX return over 5 years is better than : 56.03 vs. CADRX (4.17).
CADRXRGAHXCADRX / RGAHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years9 years-
Gain YTD22.24628.78977%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.35B306B0%
Annual Yield % from dividends0.000.64-
Returns for 1 year33.2030.15110%
Returns for 3 years-25.43-1.931,316%
Returns for 5 years4.1756.037%
Returns for 10 years1.74N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENFN9.880.19
+1.96%
Enfusion
REZI25.36N/A
N/A
Resideo Technologies
MAS79.19-0.06
-0.08%
Masco Corp
OB5.08-0.22
-4.15%
Outbrain
NRXP1.16-0.09
-7.20%
NRX Pharmaceuticals